In T2DM and CAD patients, CTRP9 is positively correlated with BMI, glucose metabolism parameters, inflammatory markers, and adhesion molecules, and is negatively correlated with adiponectin. This evidence concerns the gene ADIPOQ and coronary artery disorder.